MPPW
BIIB icon

Mitchell & Pahl Private Wealth’s Biogen BIIB Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,427
Closed -$291K – 155
2022
Q2 		$291K Sell
1,427
-231
-14% -$47.2K 0.2% 136
2022
Q1 		$349K Sell
1,658
-30
-2% -$6.52K 0.22% 130
2021
Q4 		$405K Sell
1,688
-362
-18% -$93.1K 0.26% 114
2021
Q3 		$580K Sell
2,050
-17
-0.8% -$5.57K 0.42% 80
2021
Q2 		$716K Sell
2,067
-19
-0.9% -$5.76K 0.51% 70
2021
Q1 		$584K Sell
2,086
-6
-0.3% -$1.62K 0.45% 76
2020
Q4 		$512K Buy
+2,092
New +$540K 0.43% 80

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Mitchell & Pahl Private Wealth's BIIB Position: Q3 2022 in Review

Mitchell & Pahl Private Wealth sold out of Biogen (BIIB) in Q3 2022, closing a stake of 1,427 shares — an estimated $291K sold.

Mitchell & Pahl Private Wealth first reported a position in BIIB in Q4 2020 and held it in 7 quarters. The position peaked at $716K in Q2 2021. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Mitchell & Pahl Private Wealth reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Mitchell & Pahl Private Wealth sold 1,427 Biogen shares in Q3 2022, an estimated $291K.
  • Mitchell & Pahl Private Wealth first reported a position in Biogen in Q4 2020 and held it in 7 quarters.
  • Mitchell & Pahl Private Wealth's Biogen position peaked at $716K in Q2 2021.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q3 2022, filed 1 Nov 2022.